Search results
Gilead progresses subject enrolment in HIV prevention trials
Clinical Trials Arena via Yahoo Finance· 19 hours agoGilead Sciences has announced the progression of subject enrolment in two Phase II collaborative...
Gilead Sciences: Preserving Fertility in the Face of a Cancer Diagnosis
Morningstar· 15 hours agoAccording to the National Breast Cancer Foundation, about 9% of women diagnosed with breast cancer in the United States are younger than 45 years old. While surgery and radiation rarely affect ...
... and Consistent Long-Term Efficacy and Safety Profile in Primary Biliary Cholangitis - Gilead ...
Benzinga· 22 hours agoGilead Sciences, Inc. GILD, following the recent acquisition of CymaBay Therapeutics, Inc., today announced two-year interim results from the ongoing ASSURE ...
Paulson Wealth Management Inc. Grows Stake in Gilead Sciences, Inc. (NASDAQ:GILD)
ETF DAILY NEWS· 3 days agoPaulson Wealth Management Inc. grew its position in Gilead Sciences, Inc. (NASDAQ:GILD – Free Report) by 5.3% in the 4th quarter, according to its most ...
The Zacks Analyst Blog Highlights NextEra Energy, BP, Gilead Sciences, Hamilton Beach and FONAR
Zacks via Yahoo Finance· 2 days agoStocks recently featured in the blog include: NextEra Energy, Inc. NEE, BP p.l.c. BP, Gilead ...
Vir pressures Gilead with hepatitis D cocktail showing early efficacy in phase 2
FierceBiotech· 16 hours agoVir Biotechnology's hepatitis D combination therapy has shown early efficacy in results from a phase...
Hedge Funds are Bullish on This Gene Therapy Stock
Insider Monkey via Yahoo Finance· 2 days agoWe recently compiled a list of the 9 Best Gene Therapy Stocks to Buy Now and in this article, we discuss Gilead Sciences, Inc. (NASDAQ:GILD), which is...
... Is Arcus Biosciences Stock Trading Higher Today? - Arcus Biosciences (NYSE:RCUS), Gilead ...
Benzinga· 2 days agoGilead Sciences and Arcus Biosciences report sustained efficacy and safety in the Phase 2 EDGE-Gastric study for upper GI cancers, showing improved progression-free ...
Gilead’s Phase III urothelial cancer trial fails to meet primary endpoint
Clinical Trials Arena via Yahoo Finance· 6 days agoGilead Sciences has reported that its Phase III TROPiCS-04 clinical trial of Trodelvy in patients...
Gilead's Trodelvy fails bladder cancer trial, modestly extends lung cancer survival
Reuters via AOL· 6 days ago(Reuters) -Gilead Sciences' Trodelvy failed to improve survival for patients with advanced bladder...